NAB Trademark

Trademark Overview

On Thursday, August 21, 2003, a trademark application was filed for NAB with the United States Patent and Trademark Office. The USPTO has given the NAB trademark a serial number of 78290740. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, January 15, 2018. This trademark is owned by American Bioscience, Inc.. The NAB trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical for the treatment of cancer
nab

General Information

Serial Number78290740
Word MarkNAB
Filing DateThursday, August 21, 2003
Status800 - REGISTERED AND RENEWED
Status DateMonday, January 15, 2018
Registration Number3548161
Registration DateTuesday, December 16, 2008
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 30, 2006

Trademark Statements

Goods and ServicesInjectable pharmaceutical for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2003
Primary Code005
First Use Anywhere DateMonday, November 17, 2003
First Use In Commerce DateThursday, September 18, 2008

Trademark Owner History

Party NameABRAXIS BIOSCIENCE, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSummit, NJ 07901
Party NameABRAXIS BIOSCIENCE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLOS ANGELES, CA 90025
Party NameAmerican Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90403
Party NameAmerican Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90403

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 15, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, January 15, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, January 15, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, January 15, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 18, 2017TEAS SECTION 8 & 9 RECEIVED
Saturday, December 16, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 25, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 27, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, December 27, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 16, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, December 27, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 16, 2013TEAS SECTION 8 & 15 RECEIVED
Friday, October 15, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 15, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 16, 2008REGISTERED-PRINCIPAL REGISTER
Friday, November 7, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 7, 2008ASSIGNED TO LIE
Tuesday, November 4, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 10, 2008STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 8, 2008USE AMENDMENT FILED
Thursday, October 9, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 8, 2008TEAS STATEMENT OF USE RECEIVED
Wednesday, August 20, 2008SOU EXTENSION 4 GRANTED
Wednesday, August 20, 2008SOU EXTENSION 4 FILED
Wednesday, August 20, 2008TEAS EXTENSION RECEIVED
Wednesday, February 13, 2008SOU EXTENSION 3 GRANTED
Wednesday, February 13, 2008SOU EXTENSION 3 FILED
Wednesday, February 13, 2008TEAS EXTENSION RECEIVED
Wednesday, December 5, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 15, 2007SOU EXTENSION 2 GRANTED
Wednesday, August 15, 2007SOU EXTENSION 2 FILED
Wednesday, August 15, 2007TEAS EXTENSION RECEIVED
Thursday, February 15, 2007SOU EXTENSION 1 GRANTED
Thursday, February 15, 2007SOU EXTENSION 1 FILED
Thursday, February 15, 2007TEAS EXTENSION RECEIVED
Tuesday, August 22, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 7, 2006ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 30, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2006NOTICE OF PUBLICATION
Wednesday, April 12, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 31, 2006ASSIGNED TO LIE
Monday, March 27, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 22, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 17, 2005LETTER OF SUSPENSION E-MAILED
Saturday, September 17, 2005SUSPENSION LETTER WRITTEN
Thursday, September 15, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 8, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 8, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 19, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 19, 2004LETTER OF SUSPENSION E-MAILED
Tuesday, October 19, 2004SUSPENSION LETTER WRITTEN
Monday, July 26, 2004DATA MODIFICATION COMPLETED
Monday, July 26, 2004PAPER RECEIVED
Thursday, February 5, 2004NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2004ASSIGNED TO EXAMINER

Related Keywords

cancer treatment pharmaceutical injectable